Cypre Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Cypre General Information

Description

Developer of hydrogel patterning technology and a model designed to improve the process of cancer drug development and precision medicine. The company's platform utilizes patented three-dimensional bioprinting technology and proprietary methods that synergize with high-content imaging to assay immunotherapy efficacy, enabling medical institutions to identify therapeutics that overcome cancer immunotherapy resistance.

Contact Information

Website
www.cypre.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
+1 (415)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cypre Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Seed Round 10-Jan-2024 Completed Generating Revenue
2. Seed Round 01-Feb-2017 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view Cypre’s complete valuation and funding history, request access »

Cypre Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-6
Seed-5
Seed-4
Seed-3
Seed-2 120,919 $0.000100 $1.67 $1.67 1x $1.67 2.81%
Seed-1 231,196 $0.000100 $1.05 $1.05 1x $1.05 5.36%
To view Cypre’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cypre Patents

Cypre Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024527413-A Compositions and methods for improving cancer treatment Pending 15-Jul-2021
JP-2026027314-A Compositions and methods for improving the treatment of cancer Pending 15-Jul-2021
AU-2022311934-A1 Compositions and methods for improving treatment of cancer Inactive 15-Jul-2021
EP-4370921-A1 Compositions and methods for improving treatment of cancer Inactive 15-Jul-2021
EP-4370921-A4 Compositions and methods for improving treatment of cancer Inactive 15-Jul-2021 A61K40/42
To view Cypre’s complete patent history, request access »

Cypre Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cypre Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kluz Ventures Venture Capital Minority
NOVIT Ventures Corporate Venture Capital Minority
MBC BioLabs Accelerator/Incubator Minority
To view Cypre’s complete investors history, request access »

Cypre FAQs

  • When was Cypre founded?

    Cypre was founded in 2016.

  • Where is Cypre headquartered?

    Cypre is headquartered in San Francisco, CA.

  • What is the size of Cypre?

    Cypre has 7 total employees.

  • What industry is Cypre in?

    Cypre’s primary industry is Biotechnology.

  • Is Cypre a private or public company?

    Cypre is a Private company.

  • What is Cypre’s current revenue?

    The current revenue for Cypre is .

  • How much funding has Cypre raised over time?

    Cypre has raised $1.68M.

  • Who are Cypre’s investors?

    Kluz Ventures, NOVIT Ventures, and MBC BioLabs have invested in Cypre.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process